Pseudomyxoma peritonei medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
Nima Nasiri (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Medical Therapy== | ==Medical Therapy== | ||
<ref name=Sugarbaker_2006>{{cite journal |author=Sugarbaker P |title=New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? |journal=Lancet Oncol |volume=7 |issue=1 |pages=69-76 |year=2006 |pmid=16389186}}</ref><ref name="ChenHuang2008">{{cite journal|last1=Chen|first1=Chin-Fan|last2=Huang|first2=Che-Jen|last3=Kang|first3=Wan-Yi|last4=Hsieh|first4=Jan-Sing|title=Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin / fluorouracil /leucovorin (FOLFOX4)|journal=World Journal of Surgical Oncology|volume=6|issue=1|year=2008|pages=118|issn=1477-7819|doi=10.1186/1477-7819-6-118}}</ref> | |||
== References == | == References == | ||
Revision as of 16:32, 7 January 2019
|
Pseudomyxoma peritonei Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudomyxoma peritonei medical therapy On the Web |
|
American Roentgen Ray Society Images of Pseudomyxoma peritonei medical therapy |
|
Risk calculators and risk factors for Pseudomyxoma peritonei medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The predominant therapy for pseudomyxoma peritonei is surgical resection. Supportive therapy for pseudomyxoma peritonei includes chemotherapy. Chemotherapy is infused directly into the abdominal cavity to kill cancerous cells.
Medical Therapy
References
- ↑ Sugarbaker P (2006). "New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?". Lancet Oncol. 7 (1): 69–76. PMID 16389186.
- ↑ Chen, Chin-Fan; Huang, Che-Jen; Kang, Wan-Yi; Hsieh, Jan-Sing (2008). "Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin / fluorouracil /leucovorin (FOLFOX4)". World Journal of Surgical Oncology. 6 (1): 118. doi:10.1186/1477-7819-6-118. ISSN 1477-7819.